ArticleJournal of animal science and technology2025
Knockdown of Y-box-binding protein 2 induces mitochondrial dysfunction to interrupt zygotic genome activation in porcine embryos.
Article in Journal of animal science and technology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Y-box-binding protein 2 (YBX2) is a germ cell-specific protein that plays important roles in mRNA stability, transcription, and translation. However, the effects of YBX2 on porcine embryos development remain unclear. To investigate the function of YBX2 in early porcine embryonic development, YBX2 knockdown (KD) was performed via siRNA microinjection at the single-cell stage. The expression level of YBX2 gene was measured by quantitative real-time polymerase chain reaction (qRT-PCR). The effect of YBX2 on mitochondrial function and zygotic genome activation were detected by qRT-PCR, western blot, immunofluorescence staining. The results showed that YBX2 is essential for early embryonic development. YBX2 KD decreased the blastocyst rate, mitochondrial activity, and the expression levels of NRF1, NRF2, and SIRT1, thereby reducing mitochondrial biogenesis. In addition, YBX2 KD led to an increase in maternal mRNA levels and a decrease in zygotic genome activation mRNA levels. However, maternal protein levels were reduced, indicating that YBX2 can affect the maternal-to-zygotic transition. Meanwhile, H3K9ac levels decreased and H3K9me3 levels increased following YBX2 KD, suggesting that YBX2 regulates gene transcription. YBX2 affected embryonic development by regulating mitochondrial biogenesis and ZGA expression.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.